The Triticum aesti um L. endoxylanase inhibitor (TAXI) discovered by Debyser and Delcour [(1997) 
INTRODUCTION
Cereal grains contain three groups of important biopolymers : starch, proteins and non-starch polysaccharides. Starch and a large part of the protein fraction are located in the endosperm and serve as reserve material for the plant during germination and the initial stages of growth. They are degraded by amylases and proteases respectively [1] . The non-starch polysaccharides include mainly arabinoxylan (AX) and β-glucan, which are part of the cell walls and are hydrolysed by xylanolytic and β-glucanolytic enzymes respectively [1, 2] . The degradation of these cell wall polysaccharides in the endosperm and aleurone layer during germination improves the accessibility of starch and protein for amylases and proteases [3, 4] . Proteins that inhibit amylases [5] [6] [7] [8] [9] and proteases [10] [11] [12] [13] have already been purified from cereals and have been characterized extensively. They possibly regulate the plant starch and nitrogen metabolism and\or have an important role in plant defence by inhibiting enzymic hydrolysis by micro-organisms and predators.
A new class of enzyme inhibitors, i.e. proteinaceous inhibitors of endo-β-1,4-xylanases (endoxylanases, EC 3.2.1.8), has been discovered in cereals by Debyser and Delcour [14] and Debyser et al. [15] . Inhibition activity against such xylanolytic enzymes was found in cereals such as wheat (Triticum aesti um L.), barley (Hordeum ulgare L.) and rye (Secale cereale L.) [14, 16] .
An endoxylanase inhibitor, named TAXI (T. aesti um L. endoxylanase inhibitor), was purified from wheat flour and partly characterized by Debyser and Delcour [14] and Debyser et al. [17] . TAXI has a molecular mass of approx. 40.0 kDa and occurs in two molecular forms, A and B, the latter resulting from the proteolytic modification of the former [14, 16, 17] . After reduction with 2-mercaptoethanol, the modified molecular form (B) dissociates into two fragments with molecular masses of Abbreviations used : AX, arabinoxylan ; CEC, cation-exchange chromatography ; GPC, gel-permeation chromatography ; IA B.s.
/IA
A.n. , ratio of inhibition activity against B. subtilis endoxylanase to inhibition activity against A. niger endoxylanase ; TAXI, Triticum aestivum L. endoxylanase inhibitor. 1 To whom correspondence should be addressed (e-mail kurt.gebruers!agr.kuleuven.ac.be).
ecular forms, i.e. a non-proteolytically processed one and a proteolytically processed one. However, the pI of TAXI II (at least 9.3) is higher than that of TAXI I (8.8). TAXI I and TAXI II clearly show different inhibition activities towards different endoxylanases. The N-terminal amino acid sequences of both inhibitors show a high degree of identity, which might indicate that there is an evolutionary relationship between them.
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approx. 10.0 and approx. 30.0 kDa respectively, whereas the molecular mass of the unmodified form (A) does not change on reduction. The inhibitor is heat-sensitive and has a pI of 8.8 [14, 16, 17] . Rouau and Surget [18] also found evidence for the presence of endoxylanase inhibitors in normal and durum wheats. These authors detected high inhibition activity against microbial endoxylanases in both wheat flour and bran. McLauchlan et al. [19] purified a wheat endoxylanase inhibitor structurally quite different from TAXI. It is a monomeric, glycosylated and heatsensitive protein with a pI of 8.7-8.9 and a molecular mass of 29.0 kDa. It was found to be a competitive inhibitor. Its Nterminal amino acid sequence is 87 % identical with a sequence close to the N-terminus of the rice chitinase III polypeptide chain and shows no similarity with the amino acid sequences of TAXI. The present paper demonstrates that TAXI, as described by Debyser and Delcour [14] and Debyser et al. [17] , is in fact a mixture of two endoxylanase inhibitors, namely TAXI I and TAXI II, which differ from one another in pI and endoxylanase specificity. However, the inhibitors are shown to have comparable molecular masses and structures.
EXPERIMENTAL Materials
All reagents were purchased from Sigma-Aldrich (Bornem, Belgium) and were of analytical grade unless specified otherwise.
Endoxylanase M4 and α--arabinofuranosidase (arabinofuranosidase, EC 3.2.1.55) from Aspergillus niger and azurinecross-linked wheat AX tablets were from Megazyme (Bray, Ireland). Endoxylanases from Bacillus subtilis and Aspergillus aculeatus were made available by F. Arnaut, NV Puratos (GrootBijgaarden, Belgium). BSA and a β--xylosidase (xylosidase, EC 3.2.1.37) from A. niger were purchased from Sigma-Aldrich. The Digoxigenin Glycan Detection kit2 and the Complete2 protease inhibitor cocktail tablets from Boehringer (Mannheim, Germany) and pepstatin A from Sigma-Aldrich were used.
All electrophoresis media and markers, chromatographic media and nitrocellulose blot membranes were from Pharmacia Biotech (Uppsala, Sweden).
Wheat (T. aesti um L., var. Soissons), was from AVEVE (Landen, Belgium) and was milled with a Bu$ hler MLU-202 mill (Uzwil, Switzerland).
Protein determination
Protein concentrations were determined in accordance with the Coomassie Brilliant Blue method of Bradford [20] with BSA as a standard.
Endoxylanase inhibition assay procedure
The inhibition activities of a set of samples were determined with the xylazyme-AX method as described by Debyser [16] . All endoxylanase solutions were prepared in sodium acetate buffer (25.0 mM, pH 5.0) with BSA (0.5 mg\ml) and contained 2.0 units per 1.0 ml. One enzyme unit corresponds to an increase in A &*! of 1.0 with the xylazyme-AX method (see below). Endoxylanase solution (0.5 ml) was preincubated for 30 min at room temperature with an equal amount of sample (same buffer as enzyme solution), possibly containing inhibition activity. The mixtures were kept at 30 mC and after 10 min an azurine-cross-linked wheat AX tablet was added. They were then incubated for 60 min at 30 mC. The reaction was terminated by the addition of 1.0 % (w\v) Tris solution (10.0 ml) and vigorous vortex-mixing. After 10 min at room temperature the tubes were shaken vigorously and the contents were filtered through a filter (diameter 90 mm) from Schleicher & Schuell (Dassel, Germany). The A &*! values were measured against a control, prepared by incubating the sample with buffer instead of enzyme solution, with an Ultraspec III2 UV\visible spectrophotometer (Pharmacia Biotech). The difference between the absorbance values of the samples and a control prepared by using buffer instead of sample was used as a measure of the inhibition activity, expressed as a percentage decrease in endoxylanase activity.
Protein electrophoresis
SDS\PAGE under non-reducing and reducing conditions was performed on 20 % (w\v) polyacrylamide gels with a PhastSystem2 unit (Pharmacia Biotech), by the method of Laemmli [21] . 2-Mercaptoethanol [5 % (v\v)] was used as reducing agent. The low-molecular-mass markers used were α-lactalbumin (14.0 kDa), trypsin inhibitor (20.1 kDa), carbonic anhydrase (30.0 kDa), ovalbumin (43.0 kDa), albumin (67.0 kDa) and phosphorylase b (94.0 kDa). The pI of the inhibitor was determined by using the same instrument with polyacrylamide gels containing ampholytes (pH 3-9) and with appropriate standards (Pharmacia Biotech calibration kit, pI 3.5-9.3). All gels were stained with silver in accordance with the instructions of the manufacturer (Development Technique file no. 210 ; Pharmacia Biotech).
Inhibitor purification
TAXI I and TAXI II were purified on the basis of the method of Debyser and Delcour [14] and Debyser et al. [17] (see Figure 1 ). After each purification step, the resulting fractions were assayed for endoxylanase inhibition activity with A. niger and B. subtilis endoxylanases and the purity was checked by SDS\PAGE.
Step 1 : preparation of wheat flour extract Flour (10.0 kg) was suspended in 0.1 % ascorbic acid (50.0 litres), extracted overnight at 7 mC and centrifuged (10 000 g, 30 min, 7 mC). To the supernatant, 2.0 g\l CaCl # was added and the pH was raised to 8.5 with 2.0 M NaOH to precipitate the pectins. The extract was left overnight (7 mC) and centrifuged (10 000 g, 30 min, 7 mC). The pH was adjusted to 5.0 with 2.0 M HCl.
Step 2 : concentration and partial purification by cation-exchange chromatography (CEC)
At pH 5.0, proteins with endoxylanase inhibition activity from the wheat extract were retained by CEC on an SP Sepharose2 Fast Flow column (90 mmi90 mm). The column was equilibrated with sodium acetate buffer (25 mM, pH 5.0 ; 500.0 ml) and a protein fraction was eluted with 0.5 M NaCl (1.0 litre). The eluate was dialysed against deionized water (7 mC, 48 h) and freeze-dried as the CEC material (17.0 g).
Step 3 : purification by CEC Batches of CEC material (4.0 g) in sodium acetate buffer (25 mM, pH 5.0 ; 400.0 ml) were applied to an SP Sepharose2 Fast Flow column (26 mmi100 mm) previously equilibrated with sodium acetate buffer (25 mM, pH 5.0 ; 200.0 ml). The proteins were eluted with a linear gradient of 0.0-0.5 M NaCl in 800.0 ml at a flow rate of 5.0 ml\min. Two separate fractions, one with high inhibition activity against B. subtilis and A. niger endoxylanases and one with high activity against B. subtilis endoxylanase but low activity against A. niger endoxylanase, were dialysed against deionized water (7 mC, 48 h) and freeze-dried as CEC I (4.7 g) and CEC II (2.9 g) respectively.
Step 4 : purification by gel-permeation chromatography (GPC)
Batches of CEC I (20 mg) and CEC II (20 mg) in sodium acetate buffer (250 mM, pH 5.0 ; 1.0 ml) were fractionated by GPC on a Hiprep2 Sephacryl2 S-100 column (26 mmi670 mm) with the same buffer at a flow rate of 0.7 ml\min. The active fractions were pooled as GPC I (590 mg in 2500 ml) and GPC II (320 mg in 1630 ml) respectively.
Step 5 : purification by CEC GPC I and GPC II were diluted 1 : 2. Batches of the diluted GPC I (100.0 ml) and diluted GPC II (100.0 ml) were fractionated by CEC on a MonoS2 HR 5\5 column (5 mmi50 mm) previously equilibrated with sodium acetate buffer (25 mM, pH 4.0 ; 5.0 ml) and sodium phosphate buffer (20 mM, pH 6.5 ; 5.0 ml) respectively. The bound proteins were eluted with a linear gradient of 0.0-0.6 M NaCl in 60.0 ml at a flow rate of 1.0 ml\min. The fraction thus derived from GPC I, containing inhibition activity against B. subtilis and A. niger endoxylanases, and the fraction derived from GPC II, containing activity against B. subtilis endoxylanase but not against A. niger endoxylanase, were used for further purification of TAXI I and TAXI II respectively. They were diluted 1 : 2, acidified to pH 4.0 with 1.0 M acetic acid and chromatographed again on the same MonoS2 column equilibrated with sodium acetate buffer (25 mM, pH 4.0). The same flow rate and salt gradient were used. We finally obtained 12.0 mg of TAXI I and 9.5 mg of TAXI II. Endoxylanase inhibitors
Inhibitor purification in the presence of protease inhibitors
The purification method described above was repeated on a small scale (100 g of wheat flour) with a protease inhibitor cocktail dissolved in all solutions used. For every 50 ml of solution one Complete2 protease inhibitor tablet and 1.0 mg of pepstatin A were used. Because the tablets contained EDTA to inhibit metalloproteases, no CaCl # was added in step 1. 
Protein sequencing

Glycan detection
For glycan detection, the digoxigenin glycan assay was performed as described by Roels and Delcour [22] . TAXI I (1.0 mg\ml), TAXI II (1.0 mg\ml), the positive control protein transferrin (1.0 mg\ml) and the negative control protein creatinase (1.0 mg\ml) were separated by SDS\PAGE under reducing conditions as described above, but with the sample buffer advised by the manufacturer of the Digoxigenin Glycan Detection Kit2. The proteins were electroblotted to a nitrocellulose membrane with a semi-dry PhastTransfer2 unit (Pharmacia Biotech), with an electric potential difference of 20 V for 30 min at 15 mC. On the blot the vicinal diols of the glycans were converted to aldehydes with metaperiodate and labelled with the steroid hapten digoxigenin via hydrazide. The labelled glycoconjugates were detected with a digoxigenin-specific antibody conjugated with alkaline phosphatase. In the presence of the appropriate substrate, blue-purple bands appeared where the phosphatase was present. Oxidation, labelling and detection were performed in accordance with the kit instructions (method B).
Arabinofuranosidase and xylosidase inhibition assay procedure
The method used was based on that by Cleemput et al. [23] . pNitrophenyl arabinose and p-nitrophenyl xylose were used as substrates for measuring the arabinofuranosidase and xylosidase activities respectively, in the presence and the absence of inhibitor. Substrate (0.05 mmol), arabinofuranosidase (50 µl), xylosidase (1.0 ml), TAXI I (234 µg) and TAXI II (580 µg) were dissolved separately in Mes buffer (50 mM, pH 5.5 ; 5 ml). Enzyme (25 µl) and endoxylanase inhibitor (25 µl) solutions were preincubated for 30 min at room temperature. Substrate (100 µl) was added and after 30 min at 30 mC the reaction was terminated by the addition of 1.0 % (w\v) Tris solution (1.5 ml). Finally, A %"! was measured against a control. 
RESULTS
Inhibitor purification
With the purification method described in the Experimental section, and A. niger and B. subtilis endoxylanases for assaying inhibition activity, TAXI I and TAXI II were purified to homogeneity from wheat flour. After initial fractionation by CEC on SP Sepharose2 Fast Flow columns, two protein fractions, one with high inhibition activity against B. subtilis and A. niger endoxylanases (CEC I) and one with high activity against B. subtilis endoxylanase but much lower activity against A. niger endoxylanase (CEC II), were obtained ( Figure 1 ). They were eluted at NaCl concentrations of 0.12-0. From CEC I, TAXI I was purified by GPC on a Hiprep2 Sephacryl2 S-100 column, from which it was eluted at a volume of 127.5-138.5 ml (GPC I), followed by CEC on a MonoS2 column at pH 4.0, from which it was eluted at NaCl concentrations of 0.27-0.36 M. GPC I also contained TAXI II but in much lower levels than TAXI I. With CEC on MonoS2, TAXI II, characterized by a much higher IA B.s. \IA A.n. than TAXI I (see below), resulted in an additional but smaller inhibition activity peak in the chromatogram. The final purification step was performed twice at the same pH to increase the purity of TAXI I. The chromatogram of the final separation on MonoS2 is displayed in Figure 2(A) .
TAXI II was isolated from CEC II in a similar way, but CEC on MonoS2 was performed first at pH 6.5 and secondly at pH 4.0. CEC II contained, in contrast with CEC I, much more TAXI II than TAXI I. With GPC, TAXI II was eluted at the same volume as TAXI I and with CEC on MonoS2 at pH 6.5 and 4.0, TAXI II eluted at NaCl concentrations of 0.08-0.11 M
Figure 2 MonoS2 CEC chromatogram of purified TAXI I (A) and TAXI II (B)
With the use of CEC on MonoS2 with increasing NaCl concentration (thin straight line), as described in the Experimental section, TAXI I and TAXI II were purified to homogeneity from GPC I and GPC II respectively. Only the last separations on MonoS2, performed at pH 4.0, resulting in pure TAXI I and TAXI II are shown (thick line, A 280 ).
and 0.42-0.49 M respectively. By analogy with the above, a small additional activity peak, caused by the presence of TAXI I, was observed with CEC on MonoS2 at pH 6.5. Figure 2 (B) displays the MonoS2 CEC chromatogram of almost pure TAXI II, separated at pH 4.0.
Figure 3 SDS/PAGE profiles of TAXI I (A) and TAXI II (B)
The purity and the molecular mass of TAXI I and TAXI II were assessed by SDS/PAGE, as described in the Experimental section. The gels were stained with silver. The sizes of the molecular markers are indicated at the left. Lanes 1, low-molecular-mass markers under reducing conditions ; lanes 2, TAXI I (A) and TAXI II (B) under reducing conditions ; lanes 3, TAXI I (A) and TAXI II (B) under non-reducing conditions. The gels were scanned with a Vuego Scanner (Brisa 610 S) and iPhoto Plus (version 4.0) software.
Figure 4 Isoelectric focusing gels of TAXI I (A) and TAXI II (B)
The pI of TAXI I and TAXI II was determined by isoelectric focusing, as described in the Experimental section. The gels were stained with silver. The pI values of the markers (lanes 2) are indicated at the right. Lanes 1, TAXI I (A) and TAXI II (B). The gels were scanned with a Vuego Scanner (Brisa 610 S) and iPhoto Plus (version 4.0) software.
Inhibitor characterization
The SDS\PAGE profiles (non-reducing conditions) of purified TAXI I and TAXI II show two polypeptides of approx. 40.0 kDa (Figure 3, lanes 3) . Under reducing conditions, additional polypeptides of approx. 30.0 and approx. 10.0 kDa can be seen ( Figure 3, lanes 2 ). These findings are in agreement with those of Debyser and Delcour [14] and Debyser et al. [17] . The pI of TAXI II is at least 9.3 and is therefore higher than that of TAXI I, which has a pI of 8.8 ( Figure 4) .
The N-terminal amino acid sequences of the TAXI I and TAXI II 10.0 kDa polypeptides are GAPVARAVEAVAPFG-VXYDT and GAPVARAVIPVAPFELXYXTKSLGN (singleletter amino acid codes) respectively. The 30.0 and 40.0 kDa polypeptides have the same N-terminal amino acid sequences, which for TAXI I and TAXI II are LPVLAPVTKDPATSLYT-IPFXDXA and KGLPVLAPVTKDTATSLYTIPF respectively. These results confirm the molecular structure model of TAXI by Debyser and Delcour [14] and Debyser et al. [17] . Because the Nterminal sequences of the 30.0 and 40.0 kDa polypeptides are identical, the 10.0 and 30.0 kDa polypeptides, held together by one or more disulphide bonds, are probably derived from the 40.0 kDa polypeptide by proteolytic modification. Elimination of endogenous wheat proteases during inhibitor purification by using Complete2 protease inhibitor cocktail tablets together with pepstatin A had no observable effect on the ratio of proteolytically to non-proteolytically modified TAXI I and TAXI II. The SDS\PAGE profiles under reducing and non-reducing conditions were identical with those depicted in Figure 3 . In addition, no difference in N-terminal amino acid sequences of the polypeptides of TAXI I and TAXI II from those described above could be observed.
TAXI I and TAXI II are not glycosylated, as evidenced from the Digoxigenin Glycan Detection Kit2 results. Even after 15 h of colour development, no bands appeared on the blot for both inhibitors. The positive and negative control proteins, transferrin and creatinase respectively, gave the expected results.
Inhibition activities against xylanolytic enzymes
The activities of TAXI I and TAXI II were determined on three different endoxylanases, namely those of A. aculeatus, A. niger Endoxylanase inhibitors Other xylanolytic enzymes, an arabinofuranosidase and a xylosidase from A. niger, were not inhibited by TAXI I or TAXI II.
DISCUSSION
Two endoxylanase inhibitors (TAXI I and TAXI II) were purified to homogeneity from wheat, and partly characterized. Both are non-glycosylated and have similar N-terminal amino acid sequences and SDS\PAGE profiles, indicating that there might be an evolutionary relationship between them. Their pI values are respectively approx. 8.8 and approx. 9.3 or higher. Whereas TAXI I inhibits A. niger endoxylanase to a greater extent than the B. subtilis enzyme, of these two enzymes TAXI II inhibits only B. subtilis endoxylanase. The activity of A. aculeatus endoxylanase was not affected by either TAXI I or TAXI II.
With a BLAST (version 2.0.10) search [24] , the N-terminal amino acid sequences of the 40.0, 30.0 and 10.0 kDa polypeptides of TAXI I and TAXI II were found to have no significant similarities to amino acid sequences of other documented proteins.
The present results show that Debyser and Delcour [14] and Debyser et al. [17] , in their reports on TAXI, probably studied a mixture of TAXI I and TAXI II. Indeed, mixtures of these two proteins with the above-mentioned inhibition specificities might very well have resulted in the observation that TAXI inhibited B. subtilis endoxylanase more effectively than the corresponding A. niger enzyme. Because the authors only screened with A. niger endoxylanase to purify TAXI, they probably picked up CEC I together with some material of CEC II with CEC on SP Sepharose2 Fast Flow (Figure 1) . Nevertheless, our observations are in line with the published [17] model for the molecular structure of the TAXI-type endoxylanase inhibitors, maintaining that these proteinaceous inhibitors occur in two molecular forms, A and B, with a molecular mass of approx. 40.0 kDa. According to the model, after reduction with 2-mercaptoethanol, form B dissociates into two fragments of approx. 10.0 and approx. 30.0 kDa, whereas the molecular mass of form A is not affected by the treatment. Because the N-terminal sequences of the 30.0 and 40.0 kDa polypeptides were identical, the 10.0 and 30.0 kDa polypeptides of form B, held together by one or more disulphide bonds, are probably derived from the 40.0 kDa polypeptide (form A) by proteolytic modification. We have strong indications that form A is active as endoxylanase inhibitor but it is not clear at present to what extent form B is active. It seems reasonable to assume that the first form (A) is a precursor of the second form (B) and that the inhibitor needs to be proteolytically modified to become (more) active. Such a mechanism has indeed been observed for an α-amylase inhibitor from bean (Phaseolus ulgaris L.) seeds [25, 26] . However, the described results suggest that no proteolytic modification by endogenous wheat proteases occurs during purification and that forms A and B are already present as such in wheat flour.
In contrast with TAXI-type endoxylanase inhibitors, the more recent inhibitor described by McLauchlan et al. [19] is monomeric and glycosylated and has a molecular mass of 29.0 kDa. Its Nterminal amino acid sequence is 87 % identical with a sequence of rice chitinase III in a 15-residue overlap and shows no similarity with the amino acid sequences of either TAXI I or TAXI II.
In wheat, endoxylanase inhibitors might have a dual function. They are possibly important in the regulation of plant metabolism by inhibiting endogenous endoxylanases and\or in plant defence by inhibiting exogenous endoxylanases produced by micro-organisms and predators. In contrast with exogenous endoxylanases, endogenous endoxylanases of wheat are less well documented, although Cleemput [27] and Cleemput et al. [23, 28] have purified two endoxylanases with different substrate specificities.
Further work will be needed to study the interaction of the novel proteins described here with the latter enzymes. 
